FLY

ANALYST NOTE: FLY (Firefly Aerospace Inc.) Date: 2026-06-13 Analyst: StoryStocks-Native Equity Research

1. Structural Readiness

Current State: Forming

• Current Price: $30.95
• Aggressive Entry (Pre-Breakout): $30.38
• Conservative Entry: — (Not yet actionable; requires breakout confirmation)
• Breakout Level: $73.80 (Resistance level that must be cleared to confirm the setup)
• Extension: —
• ATR Context: Current ATR is 15.1% (Extreme). This indicates significant volatility and elevated risk for position sizing, though it does not alter the structural validity of the coil itself.

2. Thesis Layer

Primary Secular Thesis: Defense Modernization → Defense Space (Tier Direct, High Confidence). Thesis Context: Firefly Aerospace is a direct beneficiary of the U.S. government's push to diversify and modernize its space launch and in-orbit capabilities. The company is positioned as a critical provider for national security initiatives, specifically through its subsidiary SciTech and its launch vehicle portfolio. Exposure Weighting: The company is a member of one primary secular theme (Defense Space). While it does not currently span multiple distinct secular themes in this setup, the "Defense Space" theme is characterized by high government spending certainty and long-term contract visibility. The directness of the exposure is high, as the company's core revenue drivers (Alpha, Eclipse, Blue Ghost) are explicitly tied to Space Force and NASA mandates.

3. Business Overview

Company Role & Model: Firefly Aerospace designs, develops, and deploys launch vehicles and dynamic spacecraft solutions. The business model is vertically integrated, covering the entire lifecycle from launch vehicle manufacturing to in-orbit operations and payload delivery. Key Products & Capabilities (as of 2026-06-13):

• Alpha: A rapid-response small-lift launch vehicle. As of the March 2026 filing, Alpha has conducted seven launches with over 30 planned launches under contract.
• Eclipse: A medium-lift launch system. The first launch is expected from Virginia's Mid-Atlantic Regional Spaceport.
• Blue Ghost: A lunar lander for payload delivery and surface operations.
• SciTech: An AI-enabled defense systems subsidiary acquired in October 2025, providing software and national security technologies.
• In-Orbit Services: Includes Elytra (maneuverability/servicing) and Ocula (lunar imaging).

Financial & Operational Evidence (Source Dates ≤ 2026-06-13):

• Revenue: The company reported record quarterly revenue of $81 million in Q1 2026 (Earnings Transcript, 2026-05-04).
• Backlog: Total backlog stood at approximately $1.3 billion as of Q1 2026, relatively flat from the prior quarter, reflecting the conversion of backlog to revenue and timing of new awards (Earnings Transcript, 2026-05-04). A March 2026 filing noted a backlog of approximately $1.4 billion as of December 31, 2025 (SEC Filing, 2026-03-20).
• Contract Awards:
• NASA: The first two phases of the NASA Moon Base architecture represent a $20 billion program with multiple shots-on-goal opportunities (Earnings Transcript, 2026-05-04).
• Space Force: SciTech was awarded contracts totaling up to $3.2 billion by the Space Force (Earnings Transcript, 2026-05-04).
• Commercial/Defense Partners: Multi-launch agreements exist with Lockheed Martin (up to 25 missions over five years) and L3Harris (up to 20 launches on Alpha, 2027–2031) (SEC Filing, 2026-03-20).
• Infrastructure: Build completion for new infrastructure is anticipated in 2026 (SEC Filing, 2026-03-20).

4. Archetype and Conviction

Archetype: Quality Compounder. Rationale: The company fits the "Quality Compounder" archetype due to its transition from a pure development stage to a revenue-generating entity with a substantial, multi-year backlog. The acquisition of SciTech and the diversification into lunar and defense software add margin inflection potential and stickiness to the customer base. Valuation & Financials:

• Profitability Status: The financial spine indicates the company is not yet profitable. Forward consensus EPS is projected at -1.94 for FY1 and -1.30 for FY2 (Financial Spine, 2026-06-12).
• Conviction Stack:
• Thesis Strength: High. The Defense Space tailwind is structural and government-backed.
• Evidence Quality: Strong. Multiple primary sources (earnings, SEC filings) confirm revenue growth, backlog accumulation, and specific contract awards.
• Structural Quality: Moderate to High. The backlog of $1.3B+ provides visibility, but the company faces execution risk regarding the Eclipse launch and regulatory delays.
• Setup Readiness: Partial. The coil is forming, offering a potential entry point, but the breakout to $73.80 is required for confirmation.
• Volatility Context: The current ATR of 15.1% is "Extreme" (well above the 4–6% historical sweet spot). This suggests that while the setup is structurally sound, price action will be volatile, requiring careful position sizing.

5. Invalidations, Strengths, and Gaps

What Would Strengthen the Case:

• Successful first launch of the Eclipse rocket as management expects.
• Conversion of the $20 billion NASA Moon Base program into specific, funded contracts.
• Expansion of the backlog beyond the current $1.3 billion level.
• Achievement of positive free cash flow or a narrowing of the EPS loss trajectory.

What Would Invalidate the Case:

• Significant regulatory delays preventing the Alpha or Eclipse launch cadence.
• Failure to execute on the multi-launch agreements with Lockheed Martin or L3Harris.

Gaps in Evidence Base:

• Margin Trajectory: While revenue is growing, there is no specific evidence in the provided text regarding the timeline for achieving GAAP profitability or the specific margin profile of the SciTech software portfolio.
• Capex Requirements: The text mentions infrastructure build completion in 2026 but does not detail the specific capital expenditure requirements or funding sources for the Eclipse development phase.
• Cash Runway: No explicit cash balance or burn rate data is provided in the evidence block to assess liquidity risk relative to the current loss profile.

PRIVATE ANALYST CALL

Judgment: Speculative Confidence: medium Key evidence: Record $81M quarterly revenue; $1.3B backlog with Space Force and NASA contract awards; SciTech acquisition integrating AI defense systems. Key risks: Extreme ATR volatility (15.1%); unprofitable status with negative forward EPS; execution risk on Eclipse launch and regulatory delays. Sizing hint: Reduce position size relative to standard setups due to extreme volatility and unconfirmed breakout. Expected path: Management expects Eclipse first launch in 2026 and continued backlog conversion; price likely to remain volatile until breakout above $73.80 or invalidation below $21.62. Expected horizon: 6 to 18 months for structural confirmation or thesis invalidation. Failure mode to watch: Price closing below $21.62, indicating the forming coil structure has failed.